These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30943749)

  • 1. The use of Human Inflammatory Response and Autoimmunity RT2 lncRNA PCR Array for plasma examination in breast cancer patients prior to therapy.
    Sterbova M; Pazourkova E; Santorova-Pospisilova S; Zednikova I; Tesarova P; Korabecna M
    Neoplasma; 2019 Jul; 66(4):641-646. PubMed ID: 30943749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating long noncoding RNA GAS5 as a potential biomarker in breast cancer for assessing the surgical effects.
    Han L; Ma P; Liu SM; Zhou X
    Tumour Biol; 2016 May; 37(5):6847-54. PubMed ID: 26662314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay of lncRNA H19/miR-675 and lncRNA NEAT1/miR-204 in breast cancer.
    Müller V; Oliveira-Ferrer L; Steinbach B; Pantel K; Schwarzenbach H
    Mol Oncol; 2019 May; 13(5):1137-1149. PubMed ID: 30803129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer.
    Ke D; Li H; Zhang Y; An Y; Fu H; Fang X; Zheng X
    Oncotarget; 2017 Mar; 8(13):21516-21525. PubMed ID: 28423525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating long non-coding HOX transcript antisense intergenic ribonucleic acid in plasma as a potential biomarker for diagnosis of breast cancer.
    Zhang Y; Zhang K; Luo Z; Liu L; Wu L; Liu J
    Thorac Cancer; 2016 Nov; 7(6):627-632. PubMed ID: 27755794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma long non-coding RNAs (lncRNAs) serve as potential biomarkers for predicting breast cancer.
    Jiao ZY; Tian Q; Li N; Wang HB; Li KZ
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1994-1999. PubMed ID: 29687854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Long Non-Coding RNAs in Breast Cancer.
    Soudyab M; Iranpour M; Ghafouri-Fard S
    Arch Iran Med; 2016 Jul; 19(7):508-17. PubMed ID: 27362246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do circulating long non-coding RNAs (lncRNAs) (LincRNA-p21, GAS 5, HOTAIR) predict the treatment response in patients with head and neck cancer treated with chemoradiotherapy?
    Fayda M; Isin M; Tambas M; Guveli M; Meral R; Altun M; Sahin D; Ozkan G; Sanli Y; Isin H; Ozgur E; Gezer U
    Tumour Biol; 2016 Mar; 37(3):3969-78. PubMed ID: 26482616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma.
    Tong YS; Wang XW; Zhou XL; Liu ZH; Yang TX; Shi WH; Xie HW; Lv J; Wu QQ; Cao XF
    Mol Cancer; 2015 Jan; 14():3. PubMed ID: 25608466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer.
    Zhang K; Luo Z; Zhang Y; Zhang L; Wu L; Liu L; Yang J; Song X; Liu J
    Cancer Biomark; 2016 Jun; 17(2):187-94. PubMed ID: 27540977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNAs differential expression in breast cancer subtypes: What do we know?
    Mathias C; Zambalde EP; Rask P; Gradia DF; de Oliveira JC
    Clin Genet; 2019 May; 95(5):558-568. PubMed ID: 30614523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression levels of breast cancer-related GAS5 and LSINCT5 lncRNAs in cancer-free breast tissue: Molecular associations with age at menarche and obesity.
    Mansoori Y; Tabei MB; Askari A; Izadi P; Daraei A; Bastami M; Naghizadeh MM; Nariman-Saleh-Fam Z; Mansoori B; Tavakkoly-Bazzaz J
    Breast J; 2018 Nov; 24(6):876-882. PubMed ID: 29785740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical significance of circulating DSCAM-AS1 in patients with ER-positive breast cancer and construction of its competitive endogenous RNA network.
    Moradi MT; Fallahi H; Rahimi Z
    Mol Biol Rep; 2020 Oct; 47(10):7685-7697. PubMed ID: 33040318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance of Long Non-coding RNA MALAT1 Expression in Tissue and Serum of Breast Cancer.
    Miao Y; Fan R; Chen L; Qian H
    Ann Clin Lab Sci; 2016 Jul; 46(4):418-24. PubMed ID: 27466303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer.
    Özgür E; Ferhatoğlu F; Şen F; Saip P; Gezer U
    Cancer Biomark; 2020; 27(1):11-17. PubMed ID: 31640083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA LY86-AS1 and HCG27_201 expression in type 2 diabetes mellitus.
    Saeidi L; Ghaedi H; Sadatamini M; Vahabpour R; Rahimipour A; Shanaki M; Mansoori Z; Kazerouni F
    Mol Biol Rep; 2018 Dec; 45(6):2601-2608. PubMed ID: 30328000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer.
    Zhang R; Xia Y; Wang Z; Zheng J; Chen Y; Li X; Wang Y; Ming H
    Biochem Biophys Res Commun; 2017 Aug; 490(2):406-414. PubMed ID: 28623135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Non-Coding RNA Expression in Laser Micro-Dissected Luminal A and Triple Negative Breast Cancer Tissue Samples-A Pilot Study.
    Marcu A; Nitusca D; Vaduva A; Baderca F; Cireap N; Coricovac D; Dehelean CA; Seclaman E; Ilina R; Marian C
    Medicina (Kaunas); 2021 Apr; 57(4):. PubMed ID: 33921283
    [No Abstract]   [Full Text] [Related]  

  • 20. Unleash multifunctional role of long noncoding RNAs biomarker panel in breast cancer: a predictor classification model.
    Toraih EA; El-Wazir A; Ageeli EA; Hussein MH; Eltoukhy MM; Killackey MT; Kandil E; Fawzy MS
    Epigenomics; 2020 Jul; 12(14):1215-1237. PubMed ID: 32812439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.